Kanasaki K - Search Results

1

Combat diabetic nephropathy: from pathogenesis to treatment.

Gohda T, Mima A, Moon JY, Kanasaki K. Gohda T, et al. Among authors: kanasaki k. J Diabetes Res. 2014;2014:207140. doi: 10.1155/2014/207140. Epub 2014 Mar 11. J Diabetes Res. 2014. PMID: 24741570 Free PMC article. No abstract available.

2

Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes.

Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D. Kitada M, et al. Among authors: kanasaki k. Exp Diabetes Res. 2011;2011:908185. doi: 10.1155/2011/908185. Epub 2011 Sep 22. Exp Diabetes Res. 2011. PMID: 21949662 Free PMC article.

3

Autophagy as a therapeutic target in diabetic nephropathy.

Tanaka Y, Kume S, Kitada M, Kanasaki K, Uzu T, Maegawa H, Koya D. Tanaka Y, et al. Among authors: kanasaki k. Exp Diabetes Res. 2012;2012:628978. doi: 10.1155/2012/628978. Epub 2011 Oct 19. Exp Diabetes Res. 2012. PMID: 22028701 Free PMC article. Review.

4

Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.

Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D. Kitada M, et al. Among authors: kanasaki k. Clin Sci (Lond). 2013 Feb;124(3):153-64. doi: 10.1042/CS20120190. Clin Sci (Lond). 2013. PMID: 23075334 Free PMC article. Review.

5

MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.

Srivastava SP, Koya D, Kanasaki K. Srivastava SP, et al. Among authors: kanasaki k. Biomed Res Int. 2013;2013:125469. doi: 10.1155/2013/125469. Epub 2013 Sep 8. Biomed Res Int. 2013. PMID: 24089659 Free PMC article. Review.

6

Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.

Koya D, Kitada M, Kume S, Kanasaki K. Koya D, et al. Among authors: kanasaki k. Clin Exp Nephrol. 2014 Apr;18(2):210-3. doi: 10.1007/s10157-013-0908-3. Epub 2013 Nov 14. Clin Exp Nephrol. 2014. PMID: 24221306 Review.

7

Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.

Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D. Kanasaki K, et al. Among authors: kanasaki m. Diabetes. 2014 Jun;63(6):2120-31. doi: 10.2337/db13-1029. Epub 2014 Feb 26. Diabetes. 2014. PMID: 24574044

8

Low-protein diet for diabetic nephropathy.

Otoda T, Kanasaki K, Koya D. Otoda T, et al. Among authors: kanasaki k. Curr Diab Rep. 2014;14(9):523. doi: 10.1007/s11892-014-0523-z. Curr Diab Rep. 2014. PMID: 24986448 Review.

9

The role of ubiquitination and sumoylation in diabetic nephropathy.

Gao C, Huang W, Kanasaki K, Xu Y. Gao C, et al. Among authors: kanasaki k. Biomed Res Int. 2014;2014:160692. doi: 10.1155/2014/160692. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24991536 Free PMC article. Review.

10

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S. Kato S, et al. Among authors: kanasaki k. Clin Exp Nephrol. 2015 Dec;19(6):1098-106. doi: 10.1007/s10157-015-1106-2. Epub 2015 Mar 21. Clin Exp Nephrol. 2015. PMID: 25795029 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page